Hepatitis E vaccine test in healthy pregnant women
Part of Infections, Women’s health & pregnancy clinical trials.
This Phase 2 study tests the safety of Hecolin® (a hepatitis E vaccine) and how well it helps the body build protection in healthy pregnant women. You might be invited if you’re pregnant during specific weeks and healthy enough for vaccination and follow-up blood tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 16 to 45
- If pregnant, be between about 14 and 35 weeks pregnant on vaccine day
- Be healthy overall, with no pregnancy complications or major health problems judged by the study doctor
- Agree to signed consent for you and (if pregnant) consent related to your baby
- Attend scheduled visits and lab tests, and be reachable during the study
- If not pregnant, use effective birth control and don’t have a positive pregnancy test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a hepatitis E vaccine called Hecolin in healthy people (ages 2–45) and in adults (18–45) living with HIV who are on antiviral treatment. It aims to see how well the vaccine works and if it's safe for different groups.
This trial tests a new hepatitis A vaccine in healthy people aged 1 year and older. It aims to see how well the vaccine prevents hepatitis A and checks for any side effects.
This trial tests a new medication called AT-587 in healthy people to see if it is safe and how the body processes it. You may help by participating if you are in good health and meet the basic requirements.
Doctors are testing a new injectable treatment for chronic hepatitis B. This first-in-human study checks the drug's safety and how well it works in people who are already on standard hepatitis B pills.
This trial tests a new protein-based vaccine to prevent hepatitis C. It is for healthy, non-smoking adults aged 18-45 who are up to date on their flu and COVID-19 vaccines.
This study is testing a new hepatitis B vaccine called SN2001 in healthy adults. It will check how safe the vaccine is, what dose works best, and how well it helps your body build protection against hepatitis B.
Hear when a new Hepatitis E Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.